Brief: Poland's Oncoarendi Therapeutics Q1 Net Loss Widens To 2.1 Mln Zlotys

Molecure SA

30/04/2021 06:32

April 30 (Reuters) - Oncoarendi Therapeutics SA  OAT.WA :
    * Q1 NET LOSS 2.1 MILLION ZLOTYS VERSUS LOSS OF 0.9 MILLION
ZLOTYS
YEAR AGO
    * Q1 REVENUE 0.2 MILLION ZLOTYS VERSUS 0.4 MILLION ZLOTYS
YEAR AGO
    * Q1 OPERATING LOSS 2.4 MILLION ZLOTYS VERSUS LOSS OF 0.9
MILLION
ZLOTYS YEAR AGO

Source text for Eikon:  ID:nEM4BPyPta 
Further company coverage:  OAT.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))